{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:28:50Z","timestamp":1764102530970},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1038\/eye.2010.112","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T09:46:33Z","timestamp":1287049593000},"page":"S1-S7","source":"Crossref","is-referenced-by-count":28,"title":["Focusing on glaucoma progression and the clinical importance of progression rate measurement: a review"],"prefix":"10.1038","volume":"24","author":[{"given":"L","family":"Rossetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Goni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Denis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Heijl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,14]]},"reference":[{"issue":"11","key":"BFeye2010112_CR1","first-page":"844","volume":"82","author":"S Resnikoff","year":"2004","unstructured":"Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82 (11): 844\u2013851.","journal-title":"Bull World Health Organ"},{"key":"BFeye2010112_CR2","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/S0161-6420(98)91133-2","volume":"105","author":"MG Hattenhauer","year":"1998","unstructured":"Hattenhauer MG, Johnson DH, Ing HH, Herman DC, Hodge DO, Yawn BP et al. The probability of blindness from open-angle glaucoma. Ophthalmology 1998; 105: 2099\u20132104.","journal-title":"Ophthalmology"},{"issue":"6","key":"BFeye2010112_CR3","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S0002-9394(02)01403-4","volume":"133","author":"JE Oliver","year":"2002","unstructured":"Oliver JE, Hattenhauer MG, Herman D, Hodge DO, Kennedy R, Fang-Yen M et al. Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol 2002; 133 (6): 764\u2013772.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2010112_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0161-6420(00)00518-2","volume":"108","author":"Collaborative Normal-Tension Glaucoma study Group","year":"2001","unstructured":"Collaborative Normal-Tension Glaucoma study Group. Natural history of normal-tension glaucoma. Ophthalmology 2001; 108: 247\u2013253.","journal-title":"Ophthalmology"},{"key":"BFeye2010112_CR5","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.ophtha.2009.06.042","volume":"116","author":"A Heijl","year":"2009","unstructured":"Heijl A, Bengtsson B, Hyman L, Leske MC, Early Manifest Glaucoma Trial Group. Natural history of open-angle glaucoma. Ophthalmology 2009; 116: 2271\u20132276.","journal-title":"Ophthalmology"},{"issue":"89","key":"BFeye2010112_CR6","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1001\/archopht.126.8.1030","volume":"126","author":"B Chauhan","year":"2008","unstructured":"Chauhan B, Mikelberg F, Balaszi AG, LeBlanc RP, Lesk MR, Trope GE, Canadian Glaucoma Study Group. Canadian glaucoma study 2 risk factors for the progression of open-angle glaucoma. Arch Ophthalmol 2008; 126 (89): 1030\u20131036.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2010112_CR7","unstructured":"European Glaucoma Society. Terminology and Guidelines for Glaucoma, 3rd edn. Savona: Italy, 2008, pp 21, 82\u201388."},{"issue":"2","key":"BFeye2010112_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1550-8579(06)80200-7","volume":"3","author":"SC White","year":"2006","unstructured":"White SC, Atchison KA, Gornbein JA, Nattiv A, Paganini-Hill A, Service SK . Risk factors for fractures in older men and women: the leisure world cohort study. Gender Med 2006; 3 (2): 110.","journal-title":"Gender Med"},{"issue":"1","key":"BFeye2010112_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1167\/iovs.08-2496","volume":"50","author":"A Kotecha","year":"2009","unstructured":"Kotecha A, O'Leary N, Melmoth D, Grant S, Crabb DP . Functional consequences of glaucoma for eye-hand coordination. Invest Ophthalmol Vis Sci 2009; 50 (1): 203\u2013213.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2010112_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1600-0420.2005.00621.x","volume":"84","author":"G Kobelt","year":"2006","unstructured":"Kobelt G, Jonsson B, Bergstr\u00f6m A, Chen E, Lind\u00e9n C, Alm A . Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden. Acta Ophthalmologica Scandinavica 2006; 84: 363\u2013371.","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"6","key":"BFeye2010112_CR11","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1185\/03007990802111068","volume":"24","author":"J Thygesen","year":"2008","unstructured":"Thygesen J, Aagren M, Arnavielle S, Bron A, Fr\u00f6hlich SJ, Baggesen K et al. Late stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries. Curr Med Res Opin 2008; 24 (6): 1763\u20131770.","journal-title":"Curr Med Res Opin"},{"key":"BFeye2010112_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/13882350590956411","volume":"7","author":"PA Aspinall","year":"2005","unstructured":"Aspinall PA, Hill AR, Nelson P, O'Brien C, O'Connell E, McCloughan L et al. Quality of life in patients with glaucoma: a conjoint analysis approach. Vis Impair Res 2005; 7: 13\u201326.","journal-title":"Vis Impair Res"},{"issue":"11","key":"BFeye2010112_CR13","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2165\/11316830-000000000-00000","volume":"26","author":"T Mills","year":"2009","unstructured":"Mills T, Law SK, Walt JW, Buchholz PM, Hansen J . The impact of glaucoma on quality of life: comparison with the chronic diseases osteoporosis, type 2 diabetes mellitus, and dementia. Drugs Aging 2009; 26 (11): 933\u2013950.","journal-title":"Drugs Aging"},{"key":"BFeye2010112_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2147\/OPTH.S6024","volume":"3","author":"K Evans","year":"2009","unstructured":"Evans K, Law S, Walt J, Buchholz P, Hansen J . The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration. Clin Ophthalmol 2009; 3: 433\u2013445.","journal-title":"Clin Ophthalmol"},{"key":"BFeye2010112_CR15","first-page":"S343","volume":"56","author":"SJ Fonda","year":"2001","unstructured":"Fonda SJ, Wallace RB, Herzog AR . Changes in driving patterns and worsening depressive symptoms among older adults. B Psychol Sci Soc Sci 2001; 56: S343\u2013S351.","journal-title":"B Psychol Sci Soc Sci"},{"key":"BFeye2010112_CR16","doi-asserted-by":"publisher","first-page":"S298","DOI":"10.1093\/geronb\/63.5.S298","volume":"63","author":"B Mezuk","year":"2008","unstructured":"Mezuk B, Rebok GW . Social integration and social support among older adults following driving cessation. J Gerontol B Psychol Sci Soc Sci 2008; 63: S298\u2013S303.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"BFeye2010112_CR17","unstructured":"Driver and Vehicle Licensing Agency. For medical practitioners: at a glance. Guide to the current medical standards of fitness to drive. Issued by Drivers Medical Group, DVLA, Swansea, 2008."},{"key":"BFeye2010112_CR18","unstructured":"Bron A, Viswanathan A, Thelen U, Di Natale R, Gundgaard J, Schwartz G et al. International vision requirements for driver licensing and disability pensions: using a milestone approach in the characterization of progressive eye disease. 2010 (in press)."},{"key":"BFeye2010112_CR19","unstructured":"European Glaucoma Society. Terminology and Guidelines for Glaucoma, 3rd ed. Savona, Italy, 2008, pp 138\u2013141."},{"key":"BFeye2010112_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bjo.2007.135012","volume":"92","author":"BC Chauhan","year":"2008","unstructured":"Chauhan BC, Garway-Heath DF, Goni FJ, Rossetti L, Bengtsson B, Viswanathan AC et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol 2008; 92: 569\u2013573.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"BFeye2010112_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajo.2007.09.038","volume":"145","author":"B Bengtsson","year":"2008","unstructured":"Bengtsson B, Heijl A . A visual field index for calculation of glaucoma rate progression. Am J Ophthalmol 2008; 145 (2): 191\u2013192.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2010112_CR22","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/archophthalmol.2009.297","volume":"127","author":"B Bengtsson","year":"2009","unstructured":"Bengtsson B, Patella M, Heijl A . Prediction of glaucomatous visual field loss by extrapolation of linear trends. Arch Ophthalmol 2009; 127: 1610\u20131615.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2010112_CR23","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/archophthalmol.2009.297","volume":"127","author":"B Bengtsson","year":"2009","unstructured":"Bengtsson B, Patella M, Heijl A . Prediction of glaucomatous visual field loss by extrapolation of linear trends. Arch Ophthalmol 2009; 127: 1610\u20131615.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"BFeye2010112_CR24","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120 (10): 1268\u20131279.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2010112_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/archopht.121.1.48","volume":"121","author":"MC Leske","year":"2003","unstructured":"Leske MC, Heijl A, Hussein M . Factors for glaucoma progression and the effect of treatment. The Early Manifest Glaucoma Trial. Arch Ophthamol 2003; 121: 52.","journal-title":"Arch Ophthamol"},{"key":"BFeye2010112_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2005.02.043","volume":"140","author":"H Barnebey","year":"2005","unstructured":"Barnebey H, Orengo-Nania S, Flowers BE, Samples J, Mallick S, Landry TA et al. The safety and efficacy of travoprost 0.004%\/timolol 0.5% fixed combination ophthalmic solution. Am J Ophthalmol 2005; 140: 1\u20137.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2010112_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/112067210701700108","volume":"17","author":"A Hommer","year":"2007","unstructured":"Hommer A, Ganfort Investigators Group I. A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%\/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension. Eur J Ophthalmol 2007; 17: 53\u201362.","journal-title":"Eur J Ophthalmol"},{"key":"BFeye2010112_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/112067210701700311","volume":"17","author":"N Jaenen","year":"2007","unstructured":"Jaenen N, Baudouin C, Pouliquen P, Manni G, Figueiredo A, Zeyen T . Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 2007; 17: 341\u2013349.","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"BFeye2010112_CR29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2105\/AJPH.83.5.711","volume":"83","author":"JH Gurwitz","year":"1993","unstructured":"Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N et al. Treatment for glaucoma: adherence by the elderly. Am J Pub Health 1993; 83 (5): 711.","journal-title":"Am J Pub Health"},{"issue":"3","key":"BFeye2010112_CR30","first-page":"234","volume":"26","author":"S Patel","year":"1995","unstructured":"Patel S, Spaeth G . Compliance in patients prescribed eye drops in glaucoma. Ophthalmic Surg 1995; 26 (3): 234\u2013235.","journal-title":"Ophthalmic Surg"},{"key":"BFeye2010112_CR31","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.ophtha.2007.01.025","volume":"114","author":"L Rossetti","year":"2007","unstructured":"Rossetti L, Karabatsas C, Topouzis F, Vetrugno M, Centofanti M, Boehm A . Comparison of the effect of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure. Ophthalmology 2007; 114: 2244\u20132251.","journal-title":"Ophthalmology"},{"key":"BFeye2010112_CR32","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/eye.2008.148","volume":"23","author":"A Martinez","year":"2009","unstructured":"Martinez A, Sanchez M . Bimatoprost\/timolol fixed combination versus latanoprost\/timolol fixed combination in open angle glaucoma patients. Eye 2009; 23: 810\u2013818.","journal-title":"Eye"},{"issue":"1","key":"BFeye2010112_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/112067210901900110","volume":"19","author":"M Centofanti","year":"2009","unstructured":"Centofanti M, Oddone F, Vetrugno M, Manni G, Fogagnolo P, Tanga L et al. Efficacy of fixed combinations of bimatoprost or latanoprost plus timolol in patients uncontrolled with prostaglandin monotherapy: a multicentre, randomized, investigator-masked, clinical study. Eur J Ophthalmol 2009; 19 (1): 66\u201371.","journal-title":"Eur J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2010112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2010112","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2010112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:10:46Z","timestamp":1684429846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2010112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":33,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["BFeye2010112"],"URL":"https:\/\/doi.org\/10.1038\/eye.2010.112","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}